相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A review of glioblastoma immunotherapy
Ravi Medikonda et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Understanding innate immune response in glioblastoma in search of a way forward
Ayush Pant et al.
NEURO-ONCOLOGY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Antibody combinations for optimized staining of macrophages in human lung tumours
Astri Frafjord et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2020)
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma
Yue Song et al.
FRONTIERS IN ONCOLOGY (2020)
Immunoadjuvants for cancer immunotherapy: A review of recent developments
Asmita Banstola et al.
ACTA BIOMATERIALIA (2020)
Management of glioblastoma: State of the art and future directions
Aaron C. Tan et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Peptide Vaccine Combined Adjuvants Modulate Anti-tumor Effects of Radiation in Glioblastoma Mouse Model
Thi-Anh-Thuy Tran et al.
FRONTIERS IN IMMUNOLOGY (2020)
Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
Ilseon Hwang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy
Nicole A. P. Lieberman et al.
NEURO-ONCOLOGY (2019)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer
Fiamma Berner et al.
JAMA ONCOLOGY (2019)
Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study
Haihui Jiang et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Mechanisms of immunotherapy resistance: lessons from glioblastoma
Christopher M. Jackson et al.
NATURE IMMUNOLOGY (2019)
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer
Yuan-sheng Zang et al.
CANCER MEDICINE (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma
Soo Jeong Nam et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade
Jorrit De Waele et al.
ONCOIMMUNOLOGY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Specific clinical and immune features of CD68 in glioma via 1,024 samples
Le Wang et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Radiation and Immunotherapy in High-grade Gliomas Where Do We Stand?
Elizabeth Reznik et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
The twilight of immunity: emerging concepts in aging of the immune system
Janko Nikolich-Zugich
NATURE IMMUNOLOGY (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients
Daniel Dubinski et al.
NEURO-ONCOLOGY (2016)
The immune mechanisms of abscopal effect in radiation therapy
G. Daniel Grass et al.
CURRENT PROBLEMS IN CANCER (2016)
Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study
Ian F. Pollack et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomasaEuro
Ian F. Pollack et al.
NEURO-ONCOLOGY (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant
Kobe Reynders et al.
CANCER TREATMENT REVIEWS (2015)
Outcome of salvage treatment for recurrent glioblastoma
Hong Rye Kim et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada et al.
LANCET ONCOLOGY (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs
Rachid Ammi et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Current Clinical Trials Testing Combinations of Immunotherapy and Radiation
Mario Crittenden et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
Mucosal Polyinosinic-Polycytidylic Acid Improves Protection Elicited by Replicating Influenza Vaccines via Enhanced Dendritic Cell Function and T Cell Immunity
Jose V. Perez-Giron et al.
JOURNAL OF IMMUNOLOGY (2014)
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
Chad Tang et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Targeting the Cytosolic Innate Immune Receptors RIG-I and MDA5 Effectively Counteracts Cancer Cell Heterogeneity in Glioblastoma
Martin Glas et al.
STEM CELLS (2013)
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners
Xinmei Zhu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Twelve immunotherapy drugs that could cure cancers
Martin A. ‘Mac’ Cheever
IMMUNOLOGICAL REVIEWS (2008)
Better influenza vaccines for older people: What will it take?
Janet E. McElhaney et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
